• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Varian Announces Alliance with Sun Nuclear to Elevate and Expand Quality Assurance Offerings

    9/30/24 8:00:00 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials
    Get the next $MIR alert in real time by email

    Varian, a Siemens Healthineers company, and Sun Nuclear, a Mirion Medical company (NYSE:MIR), announced an alliance to expand Varian's comprehensive quality assurance (QA) offerings and interoperability for current and future radiotherapy solutions.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240929726277/en/

    Agam Sharda, Vice President of Radiation Oncology Product Management for Varian; Sasa Mutic, Head of Radiation Oncology Solutions for Varian; Luis Rivera, Executive Vice President for Mirion Medical, and President for Sun Nuclear; Judith Jaensch, Director, Brachytherapy Solutions and QA Portfolio for Varian; and Bill Simon, Chief Science Officer for Sun Nuclear. (Photo: Business Wire)

    Agam Sharda, Vice President of Radiation Oncology Product Management for Varian; Sasa Mutic, Head of Radiation Oncology Solutions for Varian; Luis Rivera, Executive Vice President for Mirion Medical, and President for Sun Nuclear; Judith Jaensch, Director, Brachytherapy Solutions and QA Portfolio for Varian; and Bill Simon, Chief Science Officer for Sun Nuclear. (Photo: Business Wire)

    Under the agreement, Varian will sell Sun Nuclear's SunCHECK® quality management platform across its sales channels, broadening quality assurance support for its treatment delivery solutions. Quality assurance is a globally accepted clinical best practice, to meet international standards of care.

    "As a leader in radiation oncology, Varian understands that our quality management and quality assurance programs are paramount for providing safe and accurate patient treatments," said Sasa Mutic, PhD, Head of Radiation Oncology Solutions for Varian. "This alliance with Sun Nuclear strengthens our quality assurance offering with a portfolio of industry-leading products."

    Sun Nuclear is a market leader in radiation oncology quality management, with solutions used in more than 6,000 cancer treatment facilities. SunCHECK software is used globally by radiation therapy departments for quality management and delivery system oversight.

    "From inception, Sun Nuclear has aimed to ease radiation therapy technology adoption, enhance clinical workflows and help improve treatment outcomes on behalf of our customers," said Luis Rivera, Executive Vice President for Mirion Medical, and President for Sun Nuclear. "This alliance with Varian, a leader in the field, is an exciting opportunity to advance these goals; allowing our mutual customers to better integrate the latest technology while maintaining the level of independence critical to patient safety."

    As an integral part of Siemens Healthineers, Varian is dedicated to pioneering innovative solutions that not only advance radiotherapy, but also integrate both its imaging and therapy solutions into a cohesive ecosystem. For over 75 years, Varian's aim has been to drive breakthroughs that elevate standards and transform patient care, which relies on the highest level of quality.

    "We are continually evaluating our business, resources, and strategies to maximize the value Varian delivers to our customers and their patients," Mutic said. "With its broad range of products and a commitment to product innovation and patient safety, Sun Nuclear is ideal to strengthen Varian's QA offerings. This alliance enables Varian to expand our comprehensive quality assurance offerings, further reinforcing our commitment to excellence in patient care and safety."

    Varian will continue to support its existing QA customers, ensuring uninterrupted consistency and reliability in its offerings. Sun Nuclear's SunCHECK software will also continue to be available from Sun Nuclear and its authorized distributors.

    As part of the agreement, Varian and Sun Nuclear will also enhance the integration of QA software for future radiotherapy offerings.

    © 2024 Varian Medical Systems, Inc. All rights reserved. VARIAN is a trademark of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm.

    ©2024 Sun Nuclear Corporation. All rights reserved. SUN NUCLEAR and SUNCHECK are trademarks or registered trademarks of Mirion Technologies, Inc. and/or its affiliates in the United States and/or other countries.

    About Varian

    At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com.

    About Sun Nuclear

    Sun Nuclear is part of Mirion Medical, a group of healthcare-focused brands within Mirion (NYSE:MIR), providing innovative solutions for Radiation Therapy and Diagnostic Imaging centers. More than 6,000 cancer centers worldwide rely on Sun Nuclear for independent, integrated Quality Management. With a focus on ongoing support, Sun Nuclear aims to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety. To learn more about the company, visit: sunnuclear.com.

    About the SunCHECK platform

    Since 2014, radiation oncology teams worldwide have adopted Sun Nuclear's SunCHECK software to automate, centralize, standardize, and simplify vital patient safety processes. Through one database and one workflow, users can oversee Machine QA for a full fleet of linacs – and manage every phase of Patient QA, for a complete caseload.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240929726277/en/

    Get the next $MIR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MIR

    DatePrice TargetRatingAnalyst
    1/23/2026$29.00Equal-Weight
    Morgan Stanley
    11/25/2025$29.00Outperform
    Evercore ISI
    9/26/2025$28.00Overweight
    Analyst
    8/25/2025$26.00Outperform
    Northland Capital
    12/19/2024$22.00Outperform
    Robert W. Baird
    9/26/2024$14.00Buy
    B. Riley Securities
    5/26/2023$11.00Buy
    Citigroup
    3/24/2022$13.00Market Outperform
    CJS Securities
    More analyst ratings

    $MIR
    SEC Filings

    View All

    SEC Form 10-K filed by Mirion Technologies Inc.

    10-K - Mirion Technologies, Inc. (0001809987) (Filer)

    2/19/26 5:06:07 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Mirion Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Mirion Technologies, Inc. (0001809987) (Filer)

    2/10/26 4:17:14 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Mirion Technologies Inc.

    SCHEDULE 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

    1/21/26 1:53:12 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    $MIR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on Mirion Technologies with a new price target

    Morgan Stanley initiated coverage of Mirion Technologies with a rating of Equal-Weight and set a new price target of $29.00

    1/23/26 8:20:09 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Evercore ISI initiated coverage on Mirion Technologies with a new price target

    Evercore ISI initiated coverage of Mirion Technologies with a rating of Outperform and set a new price target of $29.00

    11/25/25 8:44:09 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Analyst initiated coverage on Mirion Technologies with a new price target

    Analyst initiated coverage of Mirion Technologies with a rating of Overweight and set a new price target of $28.00

    9/26/25 8:06:10 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    $MIR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mirion to Present at Citi's 2026 Global Industrial Tech and Mobility Conference

    Mirion (NYSE:MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Citi's 2026 Global Industrial Tech and Mobility Conference. The presentation will begin at 2:40 PM ET on Wednesday, February 18, 2026. The presentation will be webcast live at Mirion's Investor Relations Page where a webcast link will be displayed under the "Events and Presentations" section. An archive of the webcast will be available as well at the same location. About Mirion Mirion (NYSE:MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection

    2/13/26 8:30:00 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Mirion Announces Executive Appointments to Accelerate Strategic Growth and Market Focus

    Tighe Smith assumes newly created role of Chief Nuclear Officer to lead holistic global nuclear strategy. Shelia Webb transitions to President, Nuclear Medicine to lead strategic development of growing market. Shahmeer Mirza appointed first Chief Artificial Intelligence & Digital Officer to drive enterprise AI and operational excellence at Mirion. Combined, appointments reinforce Mirion's near-term execution and long-term, future-minded growth strategy. Mirion (NYSE:MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting t

    2/11/26 9:19:00 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Mirion Announces Fourth Quarter and Full Year 2025 Financial Results; Provides Full Year 2026 Guidance

    Revenues for the fourth quarter increased 9.1% to $277.4 million, compared to $254.3 million in the same period in 2024. GAAP net income was $17.8 million in the fourth quarter, compared to a GAAP net income of $15.9 million in the same period in 2024, an 11.9% improvement. Adjusted EBITDA was $77.6 million, an 11.5% increase from $69.6 million in the same period in 2024. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net earnings per share of $0.07 in 2024. Adjusted earnings per share for the quarter was $0.15, compared to $0.17 in the same period in 2024. The company announced its full year 2026 guidance for revenue growth, Organic Revenue growth

    2/10/26 4:15:00 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    $MIR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Logan Thomas D covered exercise/tax liability with 147,834 shares, was granted 318,632 shares and gifted 3,093,812 shares, decreasing direct ownership by 88% to 386,674 units (SEC Form 4)

    4 - Mirion Technologies, Inc. (0001809987) (Issuer)

    3/3/26 4:12:04 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Chief Accounting Officer (PAO) Moore Christopher A. covered exercise/tax liability with 1,397 shares and was granted 5,552 shares, increasing direct ownership by 15% to 32,460 units (SEC Form 4)

    4 - Mirion Technologies, Inc. (0001809987) (Issuer)

    3/3/26 4:12:34 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Nuclear & Safety President Eloy Loic was granted 15,577 shares, increasing direct ownership by 16% to 113,347 units (SEC Form 4)

    4 - Mirion Technologies, Inc. (0001809987) (Issuer)

    3/3/26 4:13:30 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    $MIR
    Leadership Updates

    Live Leadership Updates

    View All

    Mirion Announces Executive Appointments to Accelerate Strategic Growth and Market Focus

    Tighe Smith assumes newly created role of Chief Nuclear Officer to lead holistic global nuclear strategy. Shelia Webb transitions to President, Nuclear Medicine to lead strategic development of growing market. Shahmeer Mirza appointed first Chief Artificial Intelligence & Digital Officer to drive enterprise AI and operational excellence at Mirion. Combined, appointments reinforce Mirion's near-term execution and long-term, future-minded growth strategy. Mirion (NYSE:MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting t

    2/11/26 9:19:00 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Mirion Technologies Set to Join S&P SmallCap 600

    NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Mirion Technologies Inc. (NYSE:MIR) will replace GMS Inc. (NYSE:GMS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, September 9. S&P 500 and 100 constituent Home Depot Inc. (NYSE:HD) acquired GMS in a deal that was completed today. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector September 9, 2025 S&P SmallCap 600 Addition Mirion Technologies MIR Information Technology September 9, 2025 S&P SmallCap 600 Deletion GMS GMS Industrials For more information about S&P Dow Jones Indices, please visit www

    9/4/25 5:28:00 PM ET
    $GMS
    $HD
    $MIR
    RETAIL: Building Materials
    Consumer Discretionary
    Industrial Machinery/Components
    Industrials

    Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023

    SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail

    9/29/23 4:15:00 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    $MIR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mirion Technologies Inc.

    SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

    11/14/24 1:28:33 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

    SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

    11/13/24 6:42:31 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

    SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

    11/6/24 6:59:38 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    $MIR
    Financials

    Live finance-specific insights

    View All

    Mirion Announces Fourth Quarter and Full Year 2025 Financial Results; Provides Full Year 2026 Guidance

    Revenues for the fourth quarter increased 9.1% to $277.4 million, compared to $254.3 million in the same period in 2024. GAAP net income was $17.8 million in the fourth quarter, compared to a GAAP net income of $15.9 million in the same period in 2024, an 11.9% improvement. Adjusted EBITDA was $77.6 million, an 11.5% increase from $69.6 million in the same period in 2024. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net earnings per share of $0.07 in 2024. Adjusted earnings per share for the quarter was $0.15, compared to $0.17 in the same period in 2024. The company announced its full year 2026 guidance for revenue growth, Organic Revenue growth

    2/10/26 4:15:00 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2025

    Mirion (NYSE:MIR) announced today that it will release financial results for fourth quarter and full year 2025 after market close on Tuesday, February 10, 2026. Following the news release, the company will host a conference call the next day, Wednesday, February 11, 2026, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until February 25, 2026. Participants may access the replay at 1-844-512-2921

    1/22/26 8:30:00 AM ET
    $MIR
    Industrial Machinery/Components
    Industrials

    Mirion Announces Third Quarter 2025 Financial Results and Updates Full Year Guidance

    Revenue for the third quarter increased 7.9% to $223.1 million, compared to $206.8 million in the same period in 2024. GAAP net income was $3.1 million in the third quarter, compared to a GAAP net loss of $14.0 million in the same period in 2024; a 122% improvement. Adjusted EBITDA was $52.4 million in the third quarter, a 14.7% increase from $45.7 million in the same period in 2024. GAAP net earnings per share in the third quarter was $0.01, compared to a GAAP net loss per share of $0.07 in the same period in 2024. Adjusted earnings per share for the quarter was $0.12, compared to $0.08 in the same period in 2024. The company reaffirmed 2025 guidance for total Revenue growth, Org

    10/28/25 4:17:00 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials